Biogen · 2 hours ago
Intern, Clinical Operations (WCH)
Biogen is a mid-sized biotechnology company committed to excellence and innovation. They are seeking an intern for their West Coast Hub Clinical Operations team to support the execution of clinical trials and initiatives, offering exposure to various aspects of clinical operations.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Collaborate with cross-functional teams to gather inputs and ensure alignment on planning assumptions
Participate in planning meetings and contribute to cycle activities such as data cleaning, quality review, program acceleration, and reporting
Document learnings and propose recommendations for process improvements
Qualification
Required
Legal authorization to work in the U.S
At least 18 years of age prior to the scheduled start date
Currently enrolled in an accredited community college, college, university or skills program/apprenticeship
Excellent communication and interpersonal skills
Driven and motivated to learn and contribute to the team in a fun, collaborative environment
Someone who is a self-starter and can progress deliverables independently
Good attention to detail, ability to analyze complex data sets and present crisp and concise updates
Pursuing Degree in Preferred majors/programs: Biotechnology, Clinical Trials, Health Sciences, Other STEM-related programs
Benefits
Company paid holidays
Commuter benefits
Employee Resource Groups participation
80 hours of sick time per calendar year
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Recent News
Company data provided by crunchbase